| # | Drug | Count |
|---|---|---|
| 0 | SACUBITRIL AND VALSARTAN | 531 |
| 1 | TRASTUZUMAB | 405 |
| 2 | CYCLOPHOSPHAMIDE | 249 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 249 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 249 |
| 5 | FUROSEMIDE | 236 |
| 6 | DOXORUBICIN | 189 |
| 7 | PACLITAXEL | 163 |
| 8 | SPIRONOLACTONE | 151 |
| 9 | ASPIRIN | 139 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MILRINONE LACTATE | 3 | 0.0108 |
| 1 | CARBON DIOXIDE | 1 | 0.0087 |
| 2 | MEPIVACAINE HYDROCHLORIDE | 10 | 0.0086 |
| 3 | ONTRUZANT | 4 | 0.0077 |
| 4 | TRIHEPTANOIN | 4 | 0.0072 |
| 5 | IDARUBICIN HYDROCHLORIDE | 8 | 0.0069 |
| 6 | ANGIOTENSIN II | 2 | 0.0067 |
| 7 | SELUMETINIB | 10 | 0.0059 |
| 8 | TRASTUZUMAB | 405 | 0.0058 |
| 9 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin 2 Receptor Blocker [EPC] | 573 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 410 |
| 2 | Corticosteroid [EPC] | 340 |
| 3 | Alkylating Drug [EPC] | 290 |
| 4 | Loop Diuretic [EPC] | 266 |
| 5 | Microtubule Inhibitor [EPC] | 234 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 200 |
| 7 | Aldosterone Antagonist [EPC] | 170 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 151 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 142 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 1 | Medium-chain Triglyceride [EPC] | 4 | 0.0072 |
| 2 | Vasoconstrictor [EPC] | 2 | 0.0067 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 410 | 0.0055 |
| 4 | Prostacycline [EPC] | 4 | 0.0043 |
| 5 | Anthracycline Topoisomerase Inhibitor [EPC] | 9 | 0.0037 |
| 6 | Actinomycin [EPC] | 7 | 0.0032 |
| 7 | Antihypoglycemic Agent [EPC] | 13 | 0.0030 |
| 8 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 9 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 2 | 0.0027 |